| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.843 | 4.174 | 26.698 | 28.179 | 35.033 | 43.611 |
| Total Income - EUR | - | - | - | - | 3.843 | 4.174 | 26.951 | 28.788 | 36.831 | 44.214 |
| Total Expenses - EUR | - | - | - | - | 1.016 | 276 | 5.081 | 13.104 | 15.719 | 17.746 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.828 | 3.897 | 21.869 | 15.684 | 21.112 | 26.468 |
| Net Profit/Loss - EUR | - | - | - | - | 2.712 | 3.773 | 21.164 | 15.402 | 20.788 | 25.186 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Endowell Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 18.967 | 13.717 | 8.381 | 3.071 |
| Current Assets | - | - | - | - | 2.890 | 6.711 | 21.051 | 13.383 | 22.602 | 31.863 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 102 | 151 | 0 | 420 | 556 | 18.495 |
| Cash | - | - | - | - | 2.788 | 6.560 | 21.051 | 12.963 | 22.046 | 13.368 |
| Shareholders Funds | - | - | - | - | 2.754 | 6.475 | 27.495 | 15.466 | 22.056 | 25.246 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 135 | 236 | 10.350 | 10.062 | 7.967 | 9.336 |
| Income in Advance | - | - | - | - | 0 | 0 | 2.173 | 1.572 | 960 | 352 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endowell Medical S.r.l.